NASDAQ : PALI
Palisade Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.19 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 207.38M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Palisade Bio, Inc. (PALI) reported revenue of 500.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 500.00K | 250.00K | ||||
| Gross Profit | 500.00K | 250.00K | ||||
| Selling, General & Admin | 14.48M | 7.86M | 5.80M | 6.20M | 8.76M | 9.31M |
| Research & Development | 21.36M | 10.19M | 9.06M | 6.89M | 6.55M | 2.43M |
| Operating Expenses | 35.85M | 18.06M | 14.86M | 13.10M | 15.31M | 11.74M |
| Operating Income | -35.35M | -18.06M | -14.86M | -12.85M | -15.31M | -11.74M |
| Interest Expense | -8.00K | -10.00K | -12.00K | -15.00K | -13.00K | -3.08M |
| Interest & Investment Income | 700.00K | 200.00K | ||||
| Other Non Operating Income (Expenses) | 3.42M | 1.28M | 433.00K | 85.00K | 1.27M | 18.04M |
| EBT Excluding Unusual Items | -31.94M | -16.78M | -14.44M | -12.07M | -13.85M | 3.22M |
| Merger & Restructuring Charges | -225.00K | -410.00K | ||||
| Other Unusual Items | 279.00K | |||||
| Pretax Income | -31.94M | -16.78M | -14.44M | -12.30M | -14.26M | -26.62M |
| Net Income | -31.94M | -16.78M | -14.44M | -12.30M | -14.26M | -26.62M |
| Preferred Dividends & Other Adjustments | 16.00K | 288.00K | ||||
| Net Income to Common | -31.94M | -16.78M | -14.44M | -12.32M | -14.55M | -26.62M |
| Shares Outstanding (Basic) | 158.54M | 55.67M | 1.42M | 456.01K | 58.69K | 12.41K |
| Shares Outstanding (Diluted) | 158.54M | 55.67M | 1.42M | 456.01K | 58.69K | 12.46K |
| EPS (Basic) | -0.20 | -0.30 | -10.19 | -27.01 | -247.89 | -2,144.20 |
| EPS (Diluted) | -0.20 | -0.30 | -10.19 | -27.01 | -247.95 | -2,546.13 |
| Free Cash Flow | -18.19M | -10.85M | -12.19M | -11.14M | -13.37M | -14.77M |
| Free Cash Flow Per Share | -0.12 | -0.20 | -8.61 | -24.42 | -227.82 | -1,185.25 |
| Gross Margin | 100.00% | 100.00% | ||||
| Operating Margin | -7,069.80% | -5,138.00% | ||||
| Profit Margin | -6,388.20% | -4,926.40% | ||||
| Free Cash Flow Margin | -3,638.00% | -4,454.80% | ||||
| EBITDA | -35.35M | -18.05M | -14.86M | -12.84M | -15.31M | -11.73M |
| D&A For EBITDA | 2.50K | 3.00K | 3.00K | 4.00K | 3.00K | 2.00K |
| EBIT | -35.35M | -18.06M | -14.86M | -12.85M | -15.31M | -11.74M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 125.17M | 133.38M | 9.82M | 12.43M | 12.38M | 10.49M |
| Cash & Short-Term Investments | 125.17M | 133.38M | 9.82M | 12.43M | 12.38M | 10.49M |
| Accounts Receivable | 500.00K | |||||
| Other Receivables | 3.00K | 264.00K | 24.00K | 148.00K | 1.44M | 150.00K |
| Receivables | 503.00K | 264.00K | 24.00K | 148.00K | 1.44M | 150.00K |
| Prepaid Expenses | 1.51M | 572.00K | 574.00K | 636.00K | 798.00K | 861.00K |
| Other Current Assets | 70.00K | 75.00K | 112.00K | 114.00K | ||
| Total Current Assets | 127.26M | 134.22M | 10.49M | 13.33M | 14.73M | 11.51M |
| Property, Plant & Equipment | 87.00K | 208.00K | 310.00K | 112.00K | ||
| Other Long-Term Assets | 55.00K | 123.00K | 299.00K | 516.00K | 720.00K | 894.00K |
| Total Assets | 127.31M | 134.34M | 10.88M | 14.05M | 15.76M | 12.51M |
| Accounts Payable | 1.83M | 767.00K | 1.10M | 698.00K | 1.76M | 1.32M |
| Accrued Expenses | 3.41M | 3.48M | 1.96M | 1.61M | 1.06M | 974.00K |
| Current Portion of Long-Term Debt | 71.00K | 79.00K | 158.00K | 88.00K | 87.00K | |
| Current Portion of Leases | 90.00K | 121.00K | 105.00K | 112.00K | ||
| Other Current Liabilities | 313.00K | |||||
| Total Current Liabilities | 5.25M | 4.64M | 3.24M | 2.59M | 3.01M | 2.50M |
| Long-Term Leases | 90.00K | 211.00K | ||||
| Other Long-Term Liabilities | 321.00K | 328.00K | 152.00K | 63.00K | 61.00K | 2.65M |
| Total Liabilities | 5.57M | 4.96M | 3.39M | 2.74M | 3.28M | 5.15M |
| Common Stock | 1.74M | 1.59M | 27.00K | 6.00K | 30.00K | 3.00K |
| Additional Paid-In Capital | 292.91M | 280.51M | 143.41M | 132.81M | 121.64M | 102.00M |
| Retained Earnings | -172.90M | -152.72M | -135.94M | -121.51M | -109.19M | -94.64M |
| Total Common Equity | 121.75M | 129.38M | 7.49M | 11.31M | 12.48M | 7.36M |
| Shareholders' Equity | 121.75M | 129.38M | 7.49M | 11.31M | 12.48M | 7.37M |
| Total Liabilities & Equity | 127.31M | 134.34M | 10.88M | 14.05M | 15.76M | 12.51M |
| Total Debt | 71.00K | 169.00K | 369.00K | 404.00K | 199.00K | |
| Net Cash (Debt) | 125.17M | 133.31M | 9.65M | 12.06M | 11.98M | 10.30M |
| Net Cash Per Share | 0.79 | 2.39 | 6.81 | 26.45 | 204.12 | 826.06 |
| Filing Date Shares Outstanding | 174.27M | 165.88M | 4.40M | 851.40K | 300.26K | 24.31K |
| Total Common Shares Outstanding | 173.60M | 159.44M | 2.77M | 618.06K | 196.29K | 18.99K |
| Working Capital | 122.01M | 129.59M | 7.26M | 10.74M | 11.72M | 9.01M |
| Book Value Per Share | 0.70 | 0.81 | 2.71 | 18.30 | 63.57 | 387.81 |
| Tangible Book Value | 121.75M | 129.38M | 7.49M | 11.31M | 12.48M | 7.36M |
| Tangible Book Value Per Share | 0.70 | 0.81 | 2.71 | 18.30 | 63.57 | 387.81 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -31.94M | -16.78M | -14.44M | -12.30M | -14.26M | -26.62M |
| Depreciation & Amortization | 1.00K | 3.00K | 3.00K | 4.00K | 3.00K | 2.00K |
| Other Amortization | 75.00K | 4.91M | ||||
| Loss (Gain) From Sale of Assets | 4.00K | |||||
| Asset Writedown & Restructuring Costs | 30.12M | |||||
| Stock-Based Compensation | 12.90M | 3.96M | 652.00K | 624.00K | 1.03M | 1.89M |
| Other Operating Activities | 202.00K | 262.00K | 195.00K | 139.00K | -1.39M | -20.32M |
| Change in Accounts Receivable | -500.00K | 84.00K | ||||
| Change in Accounts Payable | 1.46M | 624.00K | 818.00K | -492.00K | 399.00K | -2.40M |
| Change in Other Net Operating Assets | -309.00K | 1.01M | 573.00K | 892.00K | 851.00K | -2.44M |
| Operating Cash Flow | -18.19M | -10.85M | -12.19M | -11.13M | -13.36M | -14.77M |
| Capital Expenditures | -4.00K | -10.00K | ||||
| Cash Acquisitions | -54.00K | |||||
| Investing Cash Flow | -4.00K | -10.00K | -54.00K | |||
| Long-Term Debt Issued | 1.25M | |||||
| Long-Term Debt Repaid | -320.00K | -426.00K | -391.00K | -790.00K | -1.43M | |
| Net Debt Issued (Repaid) | -311.00K | -320.00K | -426.00K | -391.00K | -790.00K | -183.00K |
| Issuance of Common Stock | 139.29M | 135.87M | 10.95M | 12.19M | 16.68M | 5.21M |
| Repurchase of Common Stock | -25.00K | |||||
| Other Financing Activities | -1.01M | -1.11M | -919.00K | -617.00K | -627.00K | -317.00K |
| Financing Cash Flow | 137.97M | 134.44M | 9.58M | 11.19M | 15.26M | 24.61M |
| Net Cash Flow | 119.78M | 123.59M | -2.61M | 49.00K | 1.89M | 9.78M |
| Free Cash Flow | -18.19M | -10.85M | -12.19M | -11.14M | -13.37M | -14.77M |
| Free Cash Flow Margin | -3,638.00% | -4,454.80% | ||||
| Free Cash Flow Per Share | -0.12 | -0.20 | -8.61 | -24.42 | -227.82 | -1,185.25 |
| Levered Free Cash Flow | -8.65M | -5.92M | -7.66M | -6.47M | -9.37M | -7.88M |
| Unlevered Free Cash Flow | -8.65M | -5.92M | -7.65M | -6.46M | -9.36M | -8.98M |
| Cash Interest Paid | 10.00K | 10.00K | 14.00K | 14.00K | 12.00K | 64.00K |
| Change in Working Capital | 649.00K | 1.64M | 1.39M | 400.00K | 1.25M | -4.76M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 202.15M | 350.16M | 4.56M | 5.47M | 8.02M | 17.65M |
| Enterprise Value | 76.98M | 345.14M | -3.13M | -9.34M | -5.27M | 4.24M |
| Last Close Price | 1.16 | 2.35 | 1.65 | 8.85 | 78.00 | 975.00 |
| PS Ratio | 404.31 | 21.88 | ||||
| PB Ratio | 1.65 | 2.71 | 0.61 | 0.48 | 0.64 | 2.40 |
| P/TBV Ratio | 1.66 | 2.71 | 0.61 | 0.48 | 0.64 | 2.40 |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -1.29 | -1.07 | -0.96 | -1.40 |
| Net Debt / EBITDA Ratio | 3.54 | 7.38 | 0.65 | 0.94 | 0.78 | 0.88 |
| Net Debt / FCF Ratio | 6.88 | 12.29 | 0.79 | 1.08 | 0.90 | 0.70 |
| Asset Turnover | 0.01 | 0.02 | ||||
| Quick Ratio | 23.96 | 28.83 | 3.04 | 4.87 | 4.59 | 4.26 |
| Current Ratio | 24.26 | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 |
| Return on Equity (ROE) | -51.37% | -24.52% | -153.56% | -103.40% | -143.72% | -20,012.03% |
| Return on Assets (ROA) | -32.98% | -15.54% | -74.50% | -53.85% | -67.69% | -94.46% |
| Return on Capital Employed (ROCE) | -29.00% | -13.90% | -194.40% | -112.00% | -120.10% | -117.20% |
| Earnings Yield | -17.37% | -4.79% | -316.35% | -224.87% | -177.89% | -150.84% |
| FCF Yield | -9.00% | -3.10% | -267.16% | -203.61% | -166.78% | -83.72% |
| Buyback Yield / Dilution | -4,683.09% | -3,830.18% | -210.62% | -677.03% | -370.85% |